Interplay of miRNA-146a and miRNA-126 in Chronic Periodontitis Patients With Coronary Artery Disease
1 other identifier
observational
75
1 country
1
Brief Summary
The role of micro-RNAs in chronic periodontitis associated with CAD is still in an incipient stage needs to be explored further. The investigators attempt to quantify and compare the levels of micro-RNA 146a and micro-RNA 126 in subgingival as well as coronary plaque samples obtained from patients diagnosed with chronic periodontitis with and without coronary artery disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFirst Submitted
Initial submission to the registry
October 3, 2020
CompletedFirst Posted
Study publicly available on registry
October 12, 2020
CompletedOctober 14, 2020
October 1, 2020
1.1 years
October 3, 2020
October 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
micro-RNA 146-a expression in Chronic periodontitis patients with and without coronary heart disease.
microRNA 146-a expression was present in the chronic periodontitis subjects with coronary heart disease
10 months
Levels of micro-RNA 126 in chronic periodontitis patients with and without coronary heart disease
microRNA 126 expression was present in chronic periodontitis subjects with coronary heart disease
10 months
Study Arms (3)
CP + CHD group
This was further divided into CP + CHDa (Subgingival plaque) and CP + CHDb (Coronary plaque) based on the nature of plaque collected.
CP group
25 patients with chronic periodontitis who were systemically healthy were selected
HP group
25 patients who were systemically and periodontally healthy, were considered as HP group.
Eligibility Criteria
Male subjects within 30-70 years of age were selected for the study
You may qualify if:
- Patients volunteering for the investigation.
- Patients between the age group of 30-70 years
- Presence of ≥ 15 natural teeth.
You may not qualify if:
- Patients associated with systemic diseases such as lung disorders, renal disease, liver disease, type I, type II-diabetes mellitus, HIV infection, rheumatoid arthritis, allergy or any malignancy.
- Under treatment with antibiotics, immunosuppressive drugs such as corticosteroids, within 6 months.
- Pregnant women and female patients were excluded because of the altered oral flora due to hormonal changes
- Smoking and other tobacco usage habits
- Patients who underwent periodontal treatment within 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Meenakshi Ammal Dental college
Chennai, Tamil Nadu, 600095, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Director of PG education
Study Record Dates
First Submitted
October 3, 2020
First Posted
October 12, 2020
Study Start
November 1, 2018
Primary Completion
December 1, 2019
Study Completion
December 31, 2019
Last Updated
October 14, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share